The companies are integrating Design of Experiments capabilities from Synthace with SPT Labtech's automated reagent dispenser ...

Sponsored content brought to you by When developing drugs, we rely on animal models to test drugs in an entire system before ...

Microglia have been implicated in many neurological and neurodevelopmental disorders including Alzheimer’s disease and ...

Symbiotic Capital launches with $600 million-plus in capital, about half of which has been lent to advanced-stage life ...

Scientists at the Washington University School of Medicine in St. Louis have developed an immunotherapy to minimize the damage from traumatic spinal cord injury. Their findings in mice show that ...

Scientists also found non-tumor cells that are neuron-glia hybrids, suggesting that this cell population may contribute to healthy brain function.

Recent growth in the heterogeneity of the biotech pipeline has increased demand for microbial manufacturing capacity.

HAYA is developing a pipeline of lncRNA-targeting candidates for the tissue-specific treatment of fibrotic diseases in ...

Investigational mpox mRNA vaccine, developed by Moderna, reduces disease severity in primates compared to available vaccines.

The researchers' ambition was to create a nimble, versatile ChatGPT-like AI platform that can perform a broad range of cancer ...

Controlling a biopharmaceutical continuous process is a conceptual shift for an industry built on batch-mode manufacturing.

Researchers identified a unique methylation pattern in brain stem cells that could offer a way to reprogram astrocytes to ...